Stock screenerAll disclosures →
EDGAR →
ARVN
Conviction 8HealthcareScan · Thu, Jun 25, 2026ARVN$8.02-0.37%
ResistanceSupportVol 14Insider sell5
Vol MA14 738.12K
Mar 26Apr 14May 1May 19Jun 8Jun 25
Price8.02
Change-0.37%
Gap+0.06%
Rel volume0.96×
Avg volume756.25K
Avg $ vol5.87M
SMA 207.77
SMA 509.08
SMA 20010.67
Price vs 50-11.68%
Price vs 200-24.81%
MA stackbearish
50/200 cross—
Supertrenddown · 8.36
RSI (14)46
MACD hist0.17
MACD crossbull · 6d
Stoch %K / %D70 / 79
ADX (14)28
+DI / −DI26 / 20
RSI divergence—
MACD divergenceBullish
ATR %+5.43%
ADR %5.27%
52w high13.83
52w low6.24
From 52w high-42.01%
Above 52w low+28.53%
New 52w highNo
SqueezeOff
Bollinger width27.63%
%B0.61
Donchian pos50.00%
Donchian high9.07
Donchian low6.97
AVWAP (52w high)9.90
vs AVWAP high-18.98%
AVWAP (52w low)10.04
vs AVWAP low-20.15%
OBV trendFlat
Chaikin MF (20)-0.22
Today vs 20d0.96×
Avg vol (14d)738.12K
Avg vol (20d)756.25K
Avg $ vol (20d)5.87M
Market cap517.46M
RS 3m (vs SPY)-34.03%
RS 6m (vs SPY)-38.81%
RS line new highNo
Trend template2/8
Technical rank18.8
1 week+4.56%
1 month-10.09%
3 months-26.56%
6 months-34.90%
1 year+3.62%
YTD-30.08%
P/E-6.40
P/B1.34
P/S11.08
P/FCF-1.88
EPS-1.14
Div yield—
ROE-20.89%
ROA-12.48%
Debt/Eq0.00
Current5.44
EV/EBITDA-3.73
Gross margin—
Net margin-173.02%
Rev growth114.22%
EPS growth59.38%
Price target15.09
Target upside88.15%
Analyst ratingBuy
Institutional93.72%
Ent. value430.66M
Revenue15.6M
Net income-57.6M
Gross profit—
Free cash flow-275.7M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out64.52M
Employees246
ListedThu, Sep 27, 2018
Free float51.98M
Float %80.6%
Short interest4.71M
Days to cover5.9d
Short volume57.6%
Squeeze score55 / 100
Next earningsWed, Aug 5, 2026 (41d)
EPS forecast−$0.24 · 5 est
Last EPS vs est−$0.90 vs −$0.95
Last surprise+5.3% beat
Setup gradeD
Conviction8 / 100
Pattern quality—
Tech rank18.8 / 100
Group rank50 / 100
Status laneNo active setup
Setup direction—
Pattern family
Resistance10.89
Support6.97
Days since event—
Candle confirm—
News sentiment—
Financials as of Tue, Mar 31, 2026 · quarterly.
Congress activity
Disclosed STOCK Act trades in ARVN
No recent disclosed trades by Congress in ARVN. STOCK Act filings can lag the trade by up to 45 days.
Insider activity
SEC Form 4 transactions in ARVN · 8 sells
| Insider | Side | Shares | Value | Traded | Filed |
|---|---|---|---|---|---|
Saik Andrew Chief Financial Officer · Common Stock · 2026-06-24 | Sell | 5.7K | $46K | 2026-06-24 | 2026-06-24 |
Cacace Angela M Chief Scientific Officer · Common Stock · 2026-06-17 | Sell | 2.58K | $20K | 2026-06-17 | 2026-06-18 |
Teel Randy President and CEO · Common Stock · 2026-05-21 | Sell | 2.21K | $20K | 2026-05-21 | 2026-05-22 |
Cacace Angela M Chief Scientific Officer · Common Stock · 2026-05-11 | Sell | 9.66K | $96K | 2026-05-11 | 2026-05-13 |
Berkowitz Noah Chief Medical Officer · Common Stock · 2026-05-11 | Sell | 11.11K | $110K | 2026-05-11 | 2026-05-13 |
Saik Andrew Chief Financial Officer · Common Stock · 2026-05-11 | Sell | 11.14K | $111K | 2026-05-11 | 2026-05-13 |
Loomis David K VP, Chief Accounting Officer · Common Stock · 2026-05-11 | Sell | 1.92K | $19K | 2026-05-11 | 2026-05-13 |
Teel Randy President and CEO · Common Stock · 2026-05-11 | Sell | 9.66K | $96K | 2026-05-11 | 2026-05-13 |
SEC filings
EDGAR filings in ARVN · 6 recent
Get daily signals & real-time alerts.
StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 7 days, cancel in one click.
Start free — 7-day full access →Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.